Pages that link to "Q37333995"

The following pages link to ErbB4 splice variants Cyt1 and Cyt2 differ by 16 amino acids and exert opposing effects on the mammary epithelium in vivo (Q37333995):

Displaying 46 items.

• Interactions of ErbB4 and Kap1 Connect the Growth Factor and DNA Damage Response Pathways (Q24300478) (← links)
• Neuregulin-1/erbB activities with focus on the susceptibility of the heart to anthracyclines (Q27022965) (← links)
• Proteolytic Processing of ErbB4 in Breast Cancer (Q27670640) (← links)
• Nuclear HER4 mediates acquired resistance to trastuzumab and is associated with poor outcome in HER2 positive breast cancer (Q27853060) (← links)
• Cell death or survival promoted by alternative isoforms of ErbB4 (Q28593348) (← links)
• The interaction of the ErbB4 intracellular domain p80 with α-enolase in the nuclei is associated with the inhibition of the neuregulin1-dependent cell proliferation (Q33760474) (← links)
• Immunocompetent mouse allograft models for development of therapies to target breast cancer metastasis (Q33761491) (← links)
• ERBB4 promoter polymorphism is associated with poor distant disease-free survival in high-risk early breast cancer (Q33921374) (← links)
• The localization of HER4 intracellular domain and expression of its alternately-spliced isoforms have prognostic significance in ER HER2- breast cancer (Q33977133) (← links)
• Hypoxia-inducible factor-1α induces ErbB4 signaling in the differentiating mammary gland (Q34070488) (← links)
• Deletion of ErbB4 accelerates polycystic kidney disease progression in cpk mice (Q34111793) (← links)
• EGFs and ERBBs—Brief history and prospects (Q34356008) (← links)
• Reactivation of epigenetically silenced HER4/ERBB4 results in apoptosis of breast tumor cells (Q34428718) (← links)
• Presenilin-1 processing of ErbB4 in fetal type II cells is necessary for control of fetal lung maturation. (Q34612339) (← links)
• High-throughput screening for identification of inhibitors of EpCAM-dependent growth of hepatocellular carcinoma cells (Q34860322) (← links)
• The prognostic value of Her4 receptor isoform expression in triple-negative and Her2 positive breast cancer patients (Q34996222) (← links)
• Overexpression of ERBB4 JM-a CYT-1 and CYT-2 isoforms in transgenic mice reveals isoform-specific roles in mammary gland development and carcinogenesis (Q35000695) (← links)
• Alternative splicing in oncogenic kinases: from physiological functions to cancer (Q35295203) (← links)
• A growing family: adding mutated Erbb4 as a novel cancer target (Q36062442) (← links)
• Protein inhibitor of activated STAT3 (PIAS3) protein promotes SUMOylation and nuclear sequestration of the intracellular domain of ErbB4 protein (Q36080448) (← links)
• Neuregulin 1-activated ERBB4 interacts with YAP to induce Hippo pathway target genes and promote cell migration (Q36288449) (← links)
• Neuregulin-activated ERBB4 induces the SREBP-2 cholesterol biosynthetic pathway and increases low-density lipoprotein uptake (Q36337964) (← links)
• Convergent and divergent cellular responses by ErbB4 isoforms in mammary epithelial cells (Q36505841) (← links)
• DiffSplice: the genome-wide detection of differential splicing events with RNA-seq. (Q36559327) (← links)
• Directing HER4 mRNA expression towards the CYT2 isoform by antisense oligonucleotide decreases growth of breast cancer cells in vitro and in vivo (Q36924803) (← links)
• Developmental pruning of excitatory synaptic inputs to parvalbumin interneurons in monkey prefrontal cortex. (Q37612459) (← links)
• Potential of ErbB4 antibodies for cancer therapy. (Q37658764) (← links)
• Nuclear translocation and functions of growth factor receptors (Q37935258) (← links)
• Neuregulin 3 and erbb signalling networks in embryonic mammary gland development. (Q38104664) (← links)
• Developmental pathways hijacked by osteosarcoma (Q38219835) (← links)
• Trophoblast subtype-specific EGFR/ERBB4 expression correlates with cell cycle progression and hyperplasia in complete hydatidiform moles. (Q38300650) (← links)
• ERBB4 Expression in Ovarian Serous Carcinoma Resistant to Platinum-Based Therapy (Q38971615) (← links)
• The HER4 isoform JM-a/CYT2 relates to improved survival in bladder cancer patients but only if the estrogen receptor α is not expressed. (Q39098404) (← links)
• Slow down to stay alive: HER4 protects against cellular stress and confers chemoresistance in neuroblastoma (Q39380224) (← links)
• ErbB4 modulates tubular cell polarity and lumen diameter during kidney development (Q40777975) (← links)
• ErbB3 drives mammary epithelial survival and differentiation during pregnancy and lactation (Q41467086) (← links)
• Direct coupling of the HER4 intracellular domain (4ICD) and STAT5A signaling is required to induce mammary epithelial cell differentiation (Q41682816) (← links)
• SUMOylation regulates nuclear accumulation and signaling activity of the soluble intracellular domain of the ErbB4 receptor tyrosine kinase (Q47604943) (← links)
• CSN2 gene expression is stimulated by ERBB4s80:STAT5A (Q50298061) (← links)
• Parallel microarray profiling identifies ErbB4 as a determinant of cyst growth in ADPKD and a prognostic biomarker for disease progression (Q51198669) (← links)
• HER4 isoform CYT2 and its ligand NRG1III are expressed at high levels in human colorectal cancer. (Q52608458) (← links)
• CYT-1 isoform of ErbB4 is an independent prognostic factor in serous ovarian cancer and selectively promotes ovarian cancer cell growth in vitro. (Q54457600) (← links)
• HER4 expression in estrogen receptor-positive breast cancer is associated with decreased sensitivity to tamoxifen treatment and reduced overall survival of postmenopausal women (Q59329897) (← links)
• Activation of ERBB4 in Glioblastoma Can Contribute to Increased Tumorigenicity and Influence Therapeutic Response (Q62746702) (← links)
• Function of alternative splicing (Q84837505) (← links)
• Functional role of WW domain-containing proteins in tumor biology and diseases: Insight into the role in ubiquitin-proteasome system (Q91658846) (← links)